US Patent 11939385 Activatable antibodies and methods of use thereof
Patent 11939385 was granted and assigned to ALX Oncology on March, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11939385 Activatable antibodies and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.